Asymmetric distribution of phosphoinositides and phosphatidic acid in the human erythrocyte membrane.
The distribution of phosphoinositides and phosphatidic acid (PA) between the outer and inner layers of the human erythrocyte membrane was investigated by using two complementary methodologies: hydrolysis by phospholipase A2 (PLA2) and immunofluorescence detection with monoclonal antibodies against polyphosphoinositides. The contents of phosphatidylinositol 4,5-bisphosphate (PIP2), phosphatidylinositol 4-phosphate (PIP) and PA were decreased by 15-20% after 60 min incubation with PLA2, while that of phosphatidylinositol (PI) was increased. Studies with 32P-labelled cells revealed that PLA2 treatment led to indirect effects on the metabolism of these phospholipids. Therefore, the asymmetric distribution of phosphoinositides and PA was inferred from the data obtained in ATP-depleted erythrocytes. In these cells with arrested phosphoinositide metabolism, the asymmetric distribution of the major phospholipids was maintained: PLA2 hydrolyzed approx. 20% of PI, PIP2 and PA (but no PIP) indicating their localization in the outer layer of the membrane. This finding was confirmed by immunofluorescence studies with antibodies specific to each phosphoinositide. External addition of anti-PIP2 but not anti-PIP gave a positive reaction both in control and in ATP-depleted erythrocytes. A pretreatment of cells with PLA2 led to a decrease in the intensity of anti-PIP2 staining. These results demonstrate that significant fractions of PIP2, PI and PA are localized on the outer surface of the erythrocyte membrane.
Gascard
P
P
Unité de Recherches, CNRS URA 1116, Université Paris Sud, Orsay, France.
Tran
D
D
Sauvage
M
M
Sulpice
J C
JC
Fukami
K
K
Takenawa
T
T
Claret
M
M
Giraud
F
F
D000255:Adenosine Triphosphate / Q000737:chemistry; D004789:Enzyme Activation / Q000187:drug effects; D004910:Erythrocyte Membrane / Q000737:chemistry* / Q000187:drug effects / Q000201:enzymology; D005455:Fluorescent Antibody Technique; D006801:Humans; D010712:Phosphatidic Acids / Q000097:blood*; D019269:Phosphatidylinositol 4,5-Diphosphate; D018129:Phosphatidylinositol Phosphates; D010716:Phosphatidylinositols / Q000097:blood*; D010741:Phospholipases A / Q000494:pharmacology; D054467:Phospholipases A2; D010727:Phosphoric Diester Hydrolases / Q000737:chemistry
D010712:Phosphatidic Acids; D019269:Phosphatidylinositol 4,5-Diphosphate; D018129:Phosphatidylinositol Phosphates; D010716:Phosphatidylinositols; C037178:phosphatidylinositol 4-phosphate; D000255:Adenosine Triphosphate; D010741:Phospholipases A; D054467:Phospholipases A2; D010727:Phosphoric Diester Hydrolases; C021491:glycerophosphoinositol glycerophosphodiesterase